These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 16137634)

  • 41. Generation of carrier peptides for the delivery of nucleic acid drugs in primary cells.
    Rennert R; Neundorf I; Jahnke HG; Suchowerskyj P; Dournaud P; Robitzki A; Beck-Sickinger AG
    ChemMedChem; 2008 Feb; 3(2):241-53. PubMed ID: 18205166
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Design of potent, non-toxic antimicrobial agents based upon the naturally occurring frog skin peptides, ascaphin-8 and peptide XT-7.
    Conlon JM; Galadari S; Raza H; Condamine E
    Chem Biol Drug Des; 2008 Jul; 72(1):58-64. PubMed ID: 18554256
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Live-cell analysis of cell penetration ability and toxicity of oligo-arginines.
    Tünnemann G; Ter-Avetisyan G; Martin RM; Stöckl M; Herrmann A; Cardoso MC
    J Pept Sci; 2008 Apr; 14(4):469-76. PubMed ID: 18069724
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Biological responses towards cationic peptides and drug carriers.
    Verdurmen WP; Brock R
    Trends Pharmacol Sci; 2011 Feb; 32(2):116-24. PubMed ID: 21167610
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Induction of splice correction by cell-penetrating peptide nucleic acids.
    El-Andaloussi S; Johansson HJ; Lundberg P; Langel U
    J Gene Med; 2006 Oct; 8(10):1262-73. PubMed ID: 16900561
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Creation of a novel cell penetrating peptide, using a random 18mer peptides library.
    Nomura T; Kawamura M; Shibata H; Abe Y; Ohkawa A; Mukai Y; Sugita T; Imai S; Nagano K; Okamoto T; Tsutsumi Y; Kamada H; Nakagawa S; Tsunoda S
    Pharmazie; 2007 Aug; 62(8):569-73. PubMed ID: 17867548
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cell-Penetrating Peptides Selectively Cross the Blood-Brain Barrier In Vivo.
    Stalmans S; Bracke N; Wynendaele E; Gevaert B; Peremans K; Burvenich C; Polis I; De Spiegeleer B
    PLoS One; 2015; 10(10):e0139652. PubMed ID: 26465925
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Measurement of cell-penetrating peptide-mediated transduction of adult hematopoietic stem cells.
    Manceur AP; Audet J
    Methods Mol Biol; 2009; 482():43-54. PubMed ID: 19089349
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Stability of cell-penetrating peptide-morpholino oligomer conjugates in human serum and in cells.
    Youngblood DS; Hatlevig SA; Hassinger JN; Iversen PL; Moulton HM
    Bioconjug Chem; 2007; 18(1):50-60. PubMed ID: 17226957
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interaction of neomycin with human erythrocytes.
    Di Massimo C; Mascioli A; Amicosante G; Tozzi-Ciancarelli MG
    Cell Mol Biol (Noisy-le-grand); 1993 Jun; 39(4):383-7. PubMed ID: 8392416
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Translocation or membrane disintegration? Implication of peptide-membrane interactions in pep-1 activity.
    Henriques ST; Castanho MA
    J Pept Sci; 2008 Apr; 14(4):482-7. PubMed ID: 18181239
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Coupling molecular dynamics simulations with experiments for the rational design of indolicidin-analogous antimicrobial peptides.
    Tsai CW; Hsu NY; Wang CH; Lu CY; Chang Y; Tsai HH; Ruaan RC
    J Mol Biol; 2009 Sep; 392(3):837-54. PubMed ID: 19576903
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Predicting cell-penetrating peptides.
    Hansen M; Kilk K; Langel U
    Adv Drug Deliv Rev; 2008 Mar; 60(4-5):572-9. PubMed ID: 18045726
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cell-penetrating peptides as delivery vehicles for biology and medicine.
    Stewart KM; Horton KL; Kelley SO
    Org Biomol Chem; 2008 Jul; 6(13):2242-55. PubMed ID: 18563254
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antibacterial activity of six novel peptides from Tityus discrepans scorpion venom. A fluorescent probe study of microbial membrane Na+ permeability changes.
    Díaz P; D'Suze G; Salazar V; Sevcik C; Shannon JD; Sherman NE; Fox JW
    Toxicon; 2009 Nov; 54(6):802-17. PubMed ID: 19540868
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cell selectivity and mechanism of action of short antimicrobial peptides designed from the cell-penetrating peptide Pep-1.
    Zhu WL; Hahm KS; Shin SY
    J Pept Sci; 2009 Sep; 15(9):569-75. PubMed ID: 19455552
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Membrane interactions of cell-penetrating peptides probed by tryptophan fluorescence and dichroism techniques: correlations of structure to cellular uptake.
    Caesar CE; Esbjörner EK; Lincoln P; Nordén B
    Biochemistry; 2006 Jun; 45(24):7682-92. PubMed ID: 16768464
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Exogenous siRNA delivery using peptide transduction domains/cell penetrating peptides.
    Meade BR; Dowdy SF
    Adv Drug Deliv Rev; 2007 Mar; 59(2-3):134-40. PubMed ID: 17451840
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Passage of cell-penetrating peptides across a human epithelial cell layer in vitro.
    Lindgren ME; Hällbrink MM; Elmquist AM; Langel U
    Biochem J; 2004 Jan; 377(Pt 1):69-76. PubMed ID: 12968950
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Improved method to evaluate the ability of compounds to destabilize the cellular plasma membrane.
    Cyprych K; Procek J; Langner M; Przybylo M
    Chem Phys Lipids; 2011 May; 164(4):276-82. PubMed ID: 21376712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.